Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Frequent and Specific Involvement of Changes of the p16–RB Pathway in Esophageal Neuroendocrine Carcinoma

KOICHIRO FUJIMASA, NOBUYUKI OHIKE, TOMOKO NOROSE, TOMOHIDE ISOBE, KAZUO KIKUCHI, KOJI OTSUKA, MASAHIKO MURAKAMI and MASAFUMI TAKIMOTO
Anticancer Research April 2019, 39 (4) 1927-1934; DOI: https://doi.org/10.21873/anticanres.13302
KOICHIRO FUJIMASA
1Department of Pathology and Laboratory Medicine, Showa University School of Medicine, Tokyo, Japan
2Department of Pathology and Laboratory Medicine, Showa University Fujigaoka Hospital, Yokohama, Japan
3Department of Surgery, Division of General and Gastroenterological Surgery, Showa University Hospital, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: fujimasa@med.showa-u.ac.jp
NOBUYUKI OHIKE
2Department of Pathology and Laboratory Medicine, Showa University Fujigaoka Hospital, Yokohama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TOMOKO NOROSE
2Department of Pathology and Laboratory Medicine, Showa University Fujigaoka Hospital, Yokohama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TOMOHIDE ISOBE
2Department of Pathology and Laboratory Medicine, Showa University Fujigaoka Hospital, Yokohama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KAZUO KIKUCHI
1Department of Pathology and Laboratory Medicine, Showa University School of Medicine, Tokyo, Japan
2Department of Pathology and Laboratory Medicine, Showa University Fujigaoka Hospital, Yokohama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KOJI OTSUKA
3Department of Surgery, Division of General and Gastroenterological Surgery, Showa University Hospital, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MASAHIKO MURAKAMI
3Department of Surgery, Division of General and Gastroenterological Surgery, Showa University Hospital, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MASAFUMI TAKIMOTO
1Department of Pathology and Laboratory Medicine, Showa University School of Medicine, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Esophageal neuroendocrine carcinoma (NEC). A: Solid sheets of NEC cells (asterisk). Arrows indicate coexisting intraepithelial carcinoma. hematoxylin and eosin staining, ×12.5 B: Diffuse loss of retinoblastoma protein in NEC, but not in intra-epithelial carcinoma. RB immunostaining, ×12.5. C: Diffuse overexpression of p16 protein in NEC as well as in intraepithelial carcinoma. p16 immunostaining, ×12.5.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Esophageal neuroendocrine carcinoma (NEC). A: Small-cell NEC of fusiform nuclei with finely granular chromatin, scant cytoplasm, and nuclear molding. Hematoxylin and eosin staining, ×400. B: Diffuse loss of nuclear expression of retinoblastoma protein. Note positive nuclear staining in endothelial cells as an internal control. Retinoblastoma immunostaining, ×400. C: Diffuse overexpression of p16 protein in the nucleus and cytoplasm. p16 immunostaining, ×400.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    Esophageal mixed-type neuroendocrine carcinoma (so-called MANEC). A: A mixture of tubular adenocarcinoma (upper right) and large-cell NEC (asterisk). hematoxylin and eosin staining, ×400. B: Diffuse positivity (no loss) of retinoblastoma protein. Retinoblastoma immunostaining, ×400 C: Diffuse negativity (no overexpression) of p16 protein. p16 immunostaining, ×400.

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    Esophageal neuroendocrine carcinoma (NEC) and coexisting intraepithelial carcinoma. A: Small-cell NEC (right) and coexisting intraepithelial carcinoma (asterisk). Hematoxylin and eosin staining, ×400. B: Diffuse loss of retinoblastoma protein in NEC, but not in intraepithelial carcinoma. Retinoblastoma immunostaining, ×400. C: Diffuse overexpression of p16 protein in NEC as well as in intraepithelial carcinoma. p16 immunostaining, ×400.

  • Figure 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5.

    Esophageal neuroendocrine carcinoma (NEC) and coexisting intraepithelial carcinoma. A: Small-cell NEC (right) and coexisting intraepithelial carcinoma (asterisk). Hematoxylin and eosin staining, ×400. B: Diffuse loss of retinoblastoma protein in NEC as well as in intraepithelial carcinoma. Retinoblastoma immunostaining, ×400. C: Diffuse overexpression of p16 protein in NEC as well as in intraepithelial carcinoma. p16 immunostaining, ×400.

Tables

  • Figures
  • Table I.
  • Table II.
  • Table III.
  • Table IV.
PreviousNext
Back to top

In this issue

Anticancer Research: 39 (4)
Anticancer Research
Vol. 39, Issue 4
April 2019
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Frequent and Specific Involvement of Changes of the p16–RB Pathway in Esophageal Neuroendocrine Carcinoma
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
2 + 8 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Frequent and Specific Involvement of Changes of the p16–RB Pathway in Esophageal Neuroendocrine Carcinoma
KOICHIRO FUJIMASA, NOBUYUKI OHIKE, TOMOKO NOROSE, TOMOHIDE ISOBE, KAZUO KIKUCHI, KOJI OTSUKA, MASAHIKO MURAKAMI, MASAFUMI TAKIMOTO
Anticancer Research Apr 2019, 39 (4) 1927-1934; DOI: 10.21873/anticanres.13302

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Frequent and Specific Involvement of Changes of the p16–RB Pathway in Esophageal Neuroendocrine Carcinoma
KOICHIRO FUJIMASA, NOBUYUKI OHIKE, TOMOKO NOROSE, TOMOHIDE ISOBE, KAZUO KIKUCHI, KOJI OTSUKA, MASAHIKO MURAKAMI, MASAFUMI TAKIMOTO
Anticancer Research Apr 2019, 39 (4) 1927-1934; DOI: 10.21873/anticanres.13302
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Pelvic Recurrence After Curative Resection for Rectal Adenocarcinoma: Impact of Surgery on Survival
  • Glasgow Prognostic Score Predicts Survival and Recurrence Pattern in Patients With Hepatocellular Carcinoma After Hepatectomy
  • Small Bowel Lipomatosis: An Unusual Radiological Finding in Patients With Renal Cell Cancer on Pazopanib
Show more Clinical Studies

Similar Articles

Keywords

  • esophagus
  • neuroendocrine carcinoma
  • p16–RB pathway
  • immunohistochemistry
  • MiNEN
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire